A research peptide may be advertised as:
99% pure.
Third-party tested.
HPLC verified.
Mass-spec confirmed.
But what do those statements actually mean?
For a researcher, the useful question is not simply whether a supplier says a compound was tested.
The useful question is:
What was tested, which batch was tested, which analytical method was used, and what do the results actually demonstrate?
That is where a Certificate of Analysis, commonly abbreviated COA, becomes important.
A properly documented peptide COA can provide evidence concerning the identity, chromatographic purity and traceability of a particular research batch.
But a COA also has limitations.
A 99% HPLC purity result does not automatically mean that 99% of everything physically inside a vial by weight is peptide.
A mass-spectrometry result does not automatically establish sterility.
And a laboratory report does not turn a research compound into an FDA-approved medication.
This guide explains how researchers can evaluate peptide COAs more carefully.
Peptide Sciences publishes testing information through its Lab Results page, while the site’s broader quality and transparency approach is explained on the About Peptide Sciences page.
Research Use Only: Peptide Sciences products are supplied strictly for lawful laboratory and analytical research. They are not intended for human or veterinary consumption, personal administration, diagnosis, treatment, cure or prevention of disease. See the complete Research Use Only & Legal Disclaimer.
What Is a Peptide Certificate of Analysis?
A Certificate of Analysis is a document reporting analytical information about a sample or production batch.
Depending on the compound and testing program, a peptide COA may include:
- Compound name
- Batch or lot number
- Test date
- Laboratory name
- Sample identifier
- HPLC purity
- Mass-spectrometry data
- Expected molecular mass
- Observed molecular mass
- Chromatogram
- Mass spectrum
- Quantity or assay information when tested
- Additional analytical results
Not every COA contains every measurement.
That point matters.
A COA should be interpreted according to the tests actually performed, rather than assuming that the existence of a report means every possible quality attribute was analyzed.
Peptide Sciences currently states that batches are evaluated using HPLC for purity and mass spectrometry for identity, with Certificates of Analysis made available for review through its laboratory-results program.
Why Peptide COAs Matter
Synthetic peptides can contain more than the intended target molecule.
Depending on synthesis, purification, handling and storage, material can contain peptide-related impurities or degradation products.
Possible peptide-related impurities can arise from:
- Incomplete synthesis
- Deleted amino acids
- Additional amino acids
- Side reactions
- Oxidation
- Deamidation
- Isomerization
- Aggregation
- Cleavage-related impurities
- Degradation during storage
This is why peptide quality cannot be evaluated reliably by appearance alone.
A white lyophilized cake does not prove purity.
A large cake does not prove that more peptide is present.
A professionally printed label does not prove molecular identity.
Analytical evidence provides considerably more useful information.
Start With the Batch Number
Before looking at the purity percentage, check the batch or lot number.
This is one of the most important pieces of information on a research peptide COA.
The physical product and the analytical report should be connected through a traceable identifier.
The ideal relationship is:
Product → Batch Number → Laboratory Sample → COA
Suppose a supplier manufactures three separate batches of the same research peptide.
Even though all three carry the same compound name, they are separate production runs.
The analytical result from Batch A should not automatically be presented as evidence for Batch B or Batch C.
This is why Peptide Sciences states that its product pages connect researchers with current batch documentation through its Lab Results system.
What Should Match Between the Vial and the COA?
When reviewing a research peptide, compare the documentation with the physical product.
Look for agreement between:
Compound name
The COA should identify the same compound as the product.
Batch or lot number
The identifiers should correspond.
Product strength or nominal quantity
Where applicable, the description should make sense for the product being evaluated.
Testing date
The report should correspond with the appropriate production period.
Laboratory
The organization responsible for the analytical work should be identifiable.
A laboratory report belonging to a different batch is much less useful, even if the purity number looks impressive.
What Is HPLC?
HPLC stands for:
High-Performance Liquid Chromatography
HPLC is an analytical separation technique widely used in peptide characterization.
At a simplified level, a sample is introduced into a chromatographic system and its components interact differently with the stationary and mobile phases.
Different compounds can therefore move through the system at different rates.
The instrument records a chromatogram, which commonly contains a series of peaks.
For a purified peptide sample, the principal peptide may generate a dominant chromatographic peak while other detectable components may produce smaller peaks.
The United States Pharmacopeia describes HPLC and other chromatography techniques as important tools for evaluating peptide content and impurities, alongside identity techniques such as mass spectrometry.
What Does 99% HPLC Purity Mean?
This is one of the most misunderstood peptide-testing claims.
Suppose a COA reports:
HPLC Purity: 99.2%
That generally indicates that, under the stated chromatographic method and detection conditions, approximately 99.2% of the relevant integrated chromatographic signal was attributed to the principal peak.
It does not necessarily mean:
“99.2% of everything physically inside the vial by total weight is peptide.”
Those are different concepts.
The physical contents of a lyophilized peptide preparation can also involve factors such as:
- Water or residual moisture
- Counterions
- Salts
- Residual solvents
- Formulation components where present
- Other non-peptide material
Therefore:
HPLC purity ≠ automatically net peptide content
This distinction is important when evaluating research materials.
HPLC Purity vs Peptide Content
Consider a hypothetical lyophilized sample.
The chromatographic analysis might report:
99% HPLC purity
while a separate quantitative assay could provide information about how much target peptide is actually present.
These two measurements answer different questions.
HPLC purity asks:
How dominant is the target component relative to other chromatographically detected components under this method?
Peptide content or assay asks:
How much target peptide is present in the sample?
A high-quality research workflow should not confuse the two.
This distinction is consistent with pharmaceutical peptide characterization, where identity, purity, strength/content and other quality attributes can require different analytical procedures.
Does 99% HPLC Purity Mean the Peptide Is Pharmaceutical Grade?
No.
Terms such as:
- Pharmaceutical grade
- Clinical grade
- Medical grade
- Injectable grade
should not be inferred simply from an HPLC purity percentage.
A research compound showing high chromatographic purity remains a research compound if that is how it is manufactured, labeled and supplied.
HPLC does not establish:
- FDA approval
- Clinical suitability
- Sterility
- Endotoxin status
- Medical efficacy
- Human-use authorization
unless appropriate separate testing and regulatory requirements address those questions.
Peptide Sciences expressly supplies its catalog for research rather than clinical use, as explained in the Research Use Only & Legal Disclaimer.
What Is Mass Spectrometry?
HPLC helps answer a purity question.
Mass spectrometry, often abbreviated MS, helps address identity.
Mass spectrometry measures ions according to their mass-to-charge ratio.
For peptide characterization, the observed molecular mass can be compared with the expected molecular mass of the intended peptide.
Suppose the theoretical molecular mass for a particular peptide is known.
The laboratory obtains an observed result that corresponds closely with that expected molecular mass.
That provides useful evidence supporting the identity of the material.
Peptide Sciences currently describes this as the second major component of its testing approach:
HPLC → purity
Mass spectrometry → identity
Researchers can review the site’s current testing explanation on the Peptide Sciences Lab Results page.
Why HPLC Alone Is Not Enough for Identity
A large chromatographic peak does not automatically prove that the material producing that peak is the peptide named on the label.
HPLC primarily provides separation and chromatographic information.
Identity is a separate analytical question.
FDA guidance on analytical specifications notes that identification based solely on one chromatographic retention time may not be sufficiently specific and describes combinations such as HPLC coupled with mass spectrometry as stronger approaches to identification.
That is why seeing:
99% HPLC purity
without any meaningful identity information should prompt a researcher to ask:
99% of what?
Purity has more value when the principal material has also been appropriately identified.
Why Mass Spectrometry Alone Is Not a Complete Purity Test
The reverse is also true.
A mass spectrum showing a molecular ion consistent with the expected peptide does not necessarily tell you the complete proportion of peptide-related impurities present.
This is why multiple analytical techniques are often used together.
A simplified framework is:
| Question | Common Analytical Approach |
|---|---|
| Is the expected peptide present? | Mass spectrometry / appropriate identity methods |
| What is the chromatographic purity? | HPLC |
| How much peptide is present? | Quantitative assay/content method |
| How much water remains? | Moisture analysis |
| Are certain solvents present? | Residual-solvent testing |
| Is the material sterile? | Separate sterility testing |
| What is the endotoxin level? | Separate endotoxin testing |
A good COA should therefore be read according to exactly what was measured.
Expected Mass vs Observed Mass
A mass-spectrometry report may show two useful values:
Expected molecular mass
The theoretical mass calculated for the intended peptide.
Observed molecular mass
The value detected experimentally.
The observed result should appropriately correspond with the expected molecule according to the analytical method and ionization state being reported.
However, mass data should still be interpreted by someone familiar with the technique.
Mass spectra can contain multiple charge states, adducts and other features that make the displayed numbers look different from a simple molecular-weight value.
Do not assume that every number appearing on a spectrum should exactly equal the molecular weight printed in a product catalog.
Can Mass Spectrometry Confirm the Entire Peptide Sequence?
Mass spectrometry is extremely useful for molecular characterization, but the answer depends on the method.
An intact-mass measurement can provide strong evidence that a molecule has the expected overall mass.
However, two structures can sometimes have similar or identical nominal masses.
More extensive structural characterization may require additional techniques such as:
- Tandem mass spectrometry
- Peptide mapping
- Amino-acid analysis
- NMR
- Orthogonal chromatographic methods
The United States Pharmacopeia notes that certain peptide characteristics—including isobaric or chiral amino-acid issues—can require additional analytical techniques for complete characterization.
For ordinary research sourcing, the key lesson is:
Do not interpret a single analytical number as answering every quality question.
What Is a Chromatogram?
An HPLC chromatogram is the graph produced during chromatographic analysis.
It generally shows:
- Time along the horizontal axis
- Detector response along the vertical axis
Peaks appear as components pass through the detector.
The largest peak often corresponds to the principal component.
Smaller peaks can represent impurities, degradation products or other detected components.
However, researchers should avoid simply looking at the graph and declaring:
“The big peak looks clean, so the peptide must be 99% pure.”
The reported purity should be based on proper integration and a defined analytical method.
What Should You Look for on an HPLC Report?
A useful peptide HPLC report may provide information such as:
Sample identity
Which material was analyzed?
Batch number
Which production lot does the sample represent?
Purity result
What percentage was reported?
Chromatogram
Is the analytical trace supplied?
Retention information
Where did the principal peak appear?
Test date
When was the analysis performed?
Analytical method
What chromatographic conditions or method identifiers were used?
Not every laboratory report presents all of this information in the same format.
The key is traceability and enough analytical context to understand what the reported percentage represents.
What Does “Third-Party Tested” Mean?
Third-party testing means the analytical work is performed by an organization separate from the seller or manufacturer claiming the result.
That separation can improve transparency because the supplier is not merely publishing its own internal number.
But the phrase third-party tested should still be investigated.
Ask:
- Which laboratory performed the analysis?
- Is the laboratory clearly identified?
- Is there a report number?
- Is the relevant batch identified?
- What methods were used?
- Can the report be connected to the physical product?
Peptide Sciences states that its batches are sent to an independent laboratory and that results are published through its Certificates of Analysis & Third-Party Testing page.
What Makes a Peptide COA More Useful?
A useful research peptide COA generally becomes stronger when several pieces of information appear together:
Product identification
The compound should be clearly named.
Lot or batch identification
Researchers should be able to connect the report with the vial or product.
Independent laboratory identification
The issuing organization should be identifiable.
Analytical method
The report should identify what type of testing was performed.
Purity result
For example, HPLC chromatographic purity.
Identity result
For example, molecular-mass confirmation by MS.
Testing date
The result should be associated with the relevant production period.
Supporting analytical data
Chromatograms, spectra or other supporting information can provide additional transparency.
Red Flags When Evaluating a Research Peptide COA
A COA deserves closer scrutiny when there are significant inconsistencies.
Potential warning signs include:
No batch number
There is no clear way to connect the report with a physical product.
Batch numbers do not match
The product says one thing while the report identifies another lot.
No laboratory name
The report does not make clear who actually performed the analysis.
A generic COA is reused indefinitely
One report appears to be presented as evidence for unrelated production batches.
No identity testing
A supplier advertises only a large HPLC purity number without meaningful evidence supporting the identity of the principal material.
Strange or inconsistent dates
The analytical timeline does not make sense.
Edited screenshots instead of complete reports
Important context may be missing.
Claims that go beyond the testing
For example, an HPLC result is presented as proof of sterility even though no sterility test appears on the report.
No single formatting difference proves that a COA is invalid, but inconsistencies deserve investigation.
Does a COA Prove Sterility?
No—not unless sterility was actually evaluated using an appropriate method and reported.
HPLC purity does not test sterility.
Mass spectrometry does not test sterility.
Likewise, a typical purity/identity COA should not automatically be interpreted as evidence concerning:
- Bacterial contamination
- Fungal contamination
- Endotoxins
- Particulates
unless those parameters were specifically tested.
This is one reason researchers should read the actual analytical scope instead of relying on the general phrase “lab tested.”
Does a COA Prove That a Peptide Is Safe for Human Use?
No.
A laboratory result can provide evidence concerning the characteristics that were tested.
It cannot convert a laboratory research compound into an approved medicine.
A COA does not by itself establish:
- Clinical safety
- Therapeutic efficacy
- Appropriate dosing
- Human-use approval
- Veterinary-use approval
- Prescription status
The Peptide Sciences Research Use Only policy specifically states that its research compounds are not intended for human consumption or medical use.
Does a COA Prove That a Peptide Works?
No.
Analytical quality and biological efficacy are separate questions.
Imagine a sample is:
- Correctly identified
- 99% chromatographically pure
- Properly documented
Those results tell researchers useful things about the material itself.
They do not establish that a particular biological hypothesis is correct.
Scientific efficacy questions require appropriate experimental evidence.
That may involve:
- In-vitro research
- Animal models
- Pharmacological experiments
- Controlled clinical research where applicable
- Replication
Chemical identity should not be confused with clinical evidence.
Why Appearance Cannot Replace a Peptide COA
Lyophilized peptides may appear as:
- A compact cake
- Thin material at the bottom of the vial
- Porous material
- White material
- Off-white material
- Powder-like residue
None of those observations can independently measure purity.
Likewise:
large cake ≠ necessarily more peptide
small cake ≠ necessarily less peptide
white cake ≠ automatically 99% pure
Analytical measurements are considerably more useful than photographs when evaluating identity and purity.
Why Batch Testing Matters for Peptide Blends
Batch traceability becomes particularly important with multi-component formulations.
Peptide Sciences currently maintains a dedicated Peptide Blends collection.
When several compounds are present, researchers need to understand exactly what the available analytical report evaluates.
Questions can include:
- Were individual components identified?
- Was the complete blend analyzed?
- Which analytical methods were used?
- Does the report correspond to the exact blend and lot?
Do not assume that the COA for an individual peptide automatically characterizes a completely different multi-component formulation.
COAs and Growth Hormone Peptide Research
The site’s Growth Hormone Peptides research category contains numerous separate peptides and blends.
Compounds within one research category can have very different:
- Amino-acid sequences
- Molecular masses
- Analytical characteristics
- Impurity profiles
- Stability characteristics
Therefore, one generic “growth hormone peptide” COA cannot substitute for compound- and batch-specific analytical documentation.
Researchers should evaluate the actual compound they intend to study.
COAs and Recovery-Related Peptide Research
The same principle applies to the site’s Peptides for Healing research category.
A category label organizes products by research interest.
It does not mean every compound within the category:
- Has the same structure
- Uses the same analytical method
- Shares the same molecular mass
- Produces the same HPLC chromatogram
- Can rely on the same COA
Each research material should be evaluated according to its own identity and batch documentation.
How Researchers Can Evaluate a Peptide Before Ordering
A simple documentation workflow can prevent many sourcing problems.
1. Identify the Exact Compound
Start with the molecule rather than the marketing category.
Researchers can browse the broader Peptide Sciences research catalog or the site’s Popular Peptides collection to locate relevant research materials.
2. Find the Current COA
Review the applicable Peptide Sciences Lab Results or the documentation associated with the product.
3. Confirm the Batch
Check that the report corresponds with the applicable lot.
4. Review Identity Testing
Look for evidence such as mass-spectrometry results where provided.
5. Review Purity Testing
Examine the HPLC result and available chromatogram.
6. Understand What Was Not Tested
Do not assume that an unlisted parameter was analyzed.
7. Preserve Documentation
Maintain the applicable report with experimental records where appropriate.
Peptide COA Quick Checklist
Before relying on a research peptide COA, ask:
- Does the compound name match?
- Does the batch or lot number match?
- Is the laboratory identified?
- Is the testing date shown?
- Was an identity method used?
- Was chromatographic purity measured?
- Is the reported purity clearly stated?
- Are chromatograms or spectra supplied where applicable?
- Does the report describe the actual tests performed?
- Are claims being made that go beyond those tests?
- Does the documentation belong to this batch rather than an unrelated batch?
The goal is not to find a report with the biggest percentage.
The goal is traceable analytical evidence.
Peptide Purity vs Identity vs Content
These three terms deserve to be separated.
Identity
Is the material consistent with the peptide it is supposed to be?
Mass spectrometry and other structural methods can help address identity.
Purity
How much of the measured chromatographic signal corresponds to the principal component relative to detected impurities?
HPLC is frequently used for this purpose.
Content
How much target peptide is actually present?
Quantitative assay methods are used when determining peptide content.
A strong research-quality discussion should never collapse these three concepts into one number.
Why Independent Testing Supports Research Reproducibility
Research reproducibility begins long before an experiment produces data.
If starting materials vary significantly in:
- Identity
- Purity
- Quantity
- Stability
then those differences can introduce uncertainty into experimental results.
Documented analytical testing helps researchers better characterize what went into an experiment.
That does not guarantee that every experiment will reproduce successfully.
But it reduces one important source of uncertainty:
the identity and analytical quality of the starting material.
This focus on verifiable documentation is also central to the current Peptide Sciences About Us page.
Frequently Asked Questions About Peptide COAs
What does COA stand for?
COA stands for Certificate of Analysis.
It is a document reporting analytical results associated with a sample or production batch.
What does HPLC purity mean for peptides?
HPLC purity describes the relative chromatographic purity measured under a particular analytical method.
It should not automatically be interpreted as the percentage of total vial weight consisting of peptide.
What does 99% peptide purity mean?
When based on HPLC, a reported 99% purity generally means the principal chromatographic peak represents approximately 99% of the relevant integrated signal under the stated conditions.
Always check the actual method and report.
What does mass spectrometry test in peptides?
Mass spectrometry measures mass-to-charge information and can provide evidence supporting molecular identity by comparing observed data with the expected peptide mass.
Is HPLC enough to identify a peptide?
HPLC alone may not provide sufficiently specific molecular identification. Orthogonal methods such as mass spectrometry strengthen identity characterization.
Is mass spectrometry enough to determine peptide purity?
Mass spectrometry and HPLC answer different analytical questions. Chromatography is commonly used to evaluate peptide purity and impurity profiles.
Does a peptide COA prove sterility?
Not unless sterility testing was specifically performed and reported.
Does a COA prove endotoxin levels?
Not unless an appropriate endotoxin analysis was performed and reported.
Does 99% purity mean pharmaceutical grade?
No. Analytical purity alone does not establish pharmaceutical or clinical status.
Does a COA mean a peptide is FDA approved?
No.
A COA is an analytical document, not an FDA approval.
Should each peptide batch have its own COA?
Batch-specific testing provides much stronger traceability than indefinitely reusing one historical report for unrelated production lots.
Where can I find Peptide Sciences COAs?
Visit the Peptide Sciences Lab Results page and review the documentation linked to the applicable research product.
Are Peptide Sciences products intended for human use?
No. Products are supplied strictly for laboratory and analytical research, as detailed in the Research Use Only & Legal Disclaimer.
How to Read a Peptide COA: The Bottom Line
A good research peptide COA should do more than display a large purity number.
Researchers should ask four fundamental questions:
1. What compound was tested?
Confirm identity.
2. Which batch was tested?
Confirm traceability.
3. Which analytical methods were used?
Understand what was actually measured.
4. What do the results—and their limitations—mean?
Do not make claims the analysis cannot support.
For peptide research, the most useful relationship is:
Identity + Purity + Batch Traceability + Appropriate Documentation
HPLC can provide valuable purity information.
Mass spectrometry can provide valuable identity information.
But neither technique should be interpreted as answering every possible question about a research material.
Peptide Sciences’ current approach centers on publishing third-party analytical documentation so researchers can review the evidence associated with the material rather than relying solely on marketing claims.
Researchers can continue with the Peptide Sciences Lab Results, learn more about the company through About Peptide Sciences, or explore the broader research peptide catalog.
For information about the intended scope of all products and educational materials on this website, review the Research Use Only & Legal Disclaimer.
Good research starts with knowing what is actually in the sample.